Prognostic Impact of Cyclin D1, Cyclin E and P53 on Gastroenteropancreatic Neuroendocrine Tumours

Liu, Shu-Zheng; Zhang, Fang; Chang, Yu-Xi; Ma, Jie; Li, Xu; Li, Xiao-Hong; Fan, Jin-Hu; Duan, Guang-Cai; Sun, Xi-Bin

추천

검색

자료유형: 학술저널

저자정보: Liu, Shu-Zheng (Department of Epidemiology, College of Public Health of Zhengzhou University) Zhang, Fang (The Human Resource Department, the First Affiliated Hospital of Henan University of TCM) Chang, Yu-Xi (Department of Pathology, the Tumor Affiliated Hospital of Zhengzhou University, Henan Cancer Hospital) Ma, Jie (Department of Pathology, the Tumor Affiliated Hospital of Zhengzhou University, Henan Cancer Hospital) Li, Xu (Department of Pathology, the Tumor Affiliated Hospital of Zhengzhou University, Henan Cancer Hospital) Li, Xiao-Hong (Department of Pathology, the Tumor Affiliated Hospital of Zhengzhou University, Henan Cancer Hospital) Fan, Jin-Hu (Department of Cancer Epidemiology, Cancer Institute/Hospital, Chinese Academy of Medical Sciences) Duan, Guang-Cai (Department of Epidemiology, College of Public Health of Zhengzhou University) Sun, Xi-Bin (Henan Cancer Research and Control Office, Henan Cancer Hospital)

저널정보: 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제14권 제1호

발행연도: 2013.1

수록면: 419 - 422 (4page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Conventional classifications of gastroenteropancreatic neuroendocrine tumours (GEP-NETs) are rather unsatisfactory because of the variation in survival within each subgroup. Molecular markers are being found able to predict patient outcome in more and more tumours. The aim of this study was to characterize the expression of the proteins cyclin D1, cyclin E and P53 in GEP-NETs and assess any prognostic impact. Tumor specimens from 68 patients with a complete follow-up were studied immunohistochemically for cyclin D1, cyclin E and P53 expression. High cyclin D1 and cyclin E immunostaining (${\geq}$ 5% positive nuclei) was found in 48 (71%) and 24 (35%) cases, and high P53 staining (${\geq}$ 10% positive nuclei) in 33 (49%). High expression of P53 was more common in gastric neuroendocrine tumors and related to malignant behavior, being associate with a worse prognosis on univariate analysis (RR=1.9, 95%CI=1.1-3.2). High expression of cyclin E was significantly associated with shorter survival in the univariate analysis (RR=2.0, 95%CI=1.2-3.6) and multivariate analysis (RR=2.1, 95%CI=1.1-4.0). We found no significant correlation between the expression of cyclin D1 and any clinicopathological variables. Our study indicated a prognostic relevance for cyclin E and P53 immunoreactivity. Cyclin E may be an independent prognostic factor from the 2010 WHO Classification which should be evaluated in further studies.

#Gastroenteropancreatic neuroendocrine tumor #immunohistochemistry #cyclin D1 #cyclin E #P53

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요

이 논문의 저자 정보

Liu, Shu-Zheng

소속기관 Department of Cancer Epidemiology, Henan Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou Un